Based in Sunnyvale, CA, Cepheid (Nasdaq: CPHD) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer.

Parent Company
Sunnyvale, US
Cepheid was founded in 1996 and is headquartered in Sunnyvale, US

Cepheid Office Locations

Cepheid has an office in Sunnyvale
Sunnyvale, US (HQ)
904 Building 1 E Caribbean Dr

Cepheid Financials and Metrics

Cepheid Summary

Founding Date

Cepheid is a subsidiary of Danaher

Cepheid Financials

Cepheid's revenue was reported to be $538.6 m in FY, 2015 which is a 15% increase from the previous period.
USDFY, 2013FY, 2014FY, 2015


401.3 m470.1 m538.6 m

Revenue growth, %


Cost of goods sold

207.9 m229.3 m269.9 m

Gross profit

193.4 m240.8 m268.7 m
USDFY, 2013FY, 2014FY, 2015


66.1 m96.7 m112.6 m


13 m24.3 m18.5 m

Current Assets

244 m519.1 m556.5 m


84.9 m115.8 m127.6 m
USDFY, 2013FY, 2014FY, 2015

Net Income

(18 m)(50.1 m)(48.5 m)

Accounts Receivable

(7 m)(17 m)2.3 m


(5.3 m)(5.2 m)(387 k)

Accounts Payable

17.3 m
Show all financial metrics

Cepheid Median Salaries

Source: 30 public H-1B filings from Cepheid

Traffic Overview of Cepheid

Cepheid Online and Social Media Presence

Cepheid Company Life and Culture

You may also be interested in